SCHEMBL26697220

SCHEMBL26697220

COC(=O)C(=C(OC)OC)c1ccccc1Oc1cc(Cl)ncn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 3/20 0.37
ATM Q13315 2/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
MAPK8 P45983 4/20 0.35
MAPK10 P53779 4/20 0.35
RAB9A P51151 3/20 0.34
HTT P42858 2/20 0.34
NPC1 O15118 2/20 0.34
RORB Q92753 2/20 0.34
LMNA P02545 2/20 0.34
MAPT P10636 2/20 0.34
RORC P51449 1/20 0.34
HSP90AA1 P07900 1/20 0.34
XBP1 P17861 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29738609 1.00 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MEN1KMT2ANPSR1
SCHEMBL28765809 0.90 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MEN1KMT2ANPSR1
SCHEMBL709626 0.83 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MEN1KMT2ANPSR1
SCHEMBL27075764 0.83 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MEN1KMT2ANPSR1
SCHEMBL15298018 0.83 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MEN1KMT2ANPSR1
SCHEMBL12503892 0.83 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2MEN1KMT2ANPSR1
SCHEMBL17907397 0.82 PYGL (0.41) ALDH1A1SMN1; SMN2NPSR1ATMCYP1A2
SCHEMBL4306278 0.81 ALDH1A1 (0.42) ALDH1A1SMN1; SMN2MEN1KMT2ANPSR1
SCHEMBL709624 0.81 SMN1; SMN2 (0.42) ALDH1A1SMN1; SMN2MEN1KMT2ANPSR1
SCHEMBL31493947 0.81 SMN1; SMN2 (0.42) ALDH1A1SMN1; SMN2MEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240383864-A1 METHOD FOR PREPARING AZOXYSTROBIN AND INTERMEDIATE THEREOF ANHUI GUANGXIN AGROCHEMICAL CO., LTD. (CN) 2024-11-21 US disclosed
CN-114957134-B Method for preparing azoxystrobin and intermediate thereof 安徽广信农化股份有限公司 2024-07-16 CN disclosed
CN-118084805-A Method for preparing azoxystrobin and intermediate thereof 安徽广信农化股份有限公司 2024-05-28 CN disclosed
CN-118084806-A Method for preparing azoxystrobin and intermediate thereof 安徽广信农化股份有限公司 2024-05-28 CN disclosed
CN-117624059-A (E) Preparation method of (E) -2- [2- (6-chloropyrimidine-4-yloxy) phenyl ] -3-methoxy methyl acrylate 北京颖泰嘉和生物科技股份有限公司 2024-03-01 CN disclosed
EP-4317137-A1 METHOD FOR PREPARING AZOXYSTROBIN AND INTERMEDIATE THEREOF Anhui Guangxin Agrochemical Co., Ltd. (CN) 2024-02-07 EP disclosed
WO-2023226456-A1 METHOD FOR PREPARING AZOXYSTROBIN AND INTERMEDIATE THEREOF 安徽广信农化股份有限公司 2023-11-30 WO disclosed
CN-114957134-A Method for preparing azoxystrobin and intermediate thereof 安徽广信农化股份有限公司 2022-08-30 CN disclosed
CN-114685375-A Preparation method of [2- (6-chloropyrimidine-4-oxygen) phenyl ] -3, 3-dimethoxyacrylic acid methyl ester 北京颖泰嘉和生物科技股份有限公司 2022-07-01 CN disclosed
CN-114685375-A Preparation method of [2- (6-chloropyrimidine-4-oxygen) phenyl ] -3, 3-dimethoxyacrylic acid methyl ester 北京颖泰嘉和生物科技股份有限公司 2022-07-01 CN disclosed
CN-114685376-A Preparation method of azoxystrobin intermediate 北京颖泰嘉和生物科技股份有限公司 2022-07-01 CN disclosed
CN-109529928-B Catalyst system and method for preparing azoxystrobin or intermediate thereof by using same 河北威远生物化工有限公司 2021-06-29 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240383864-A1 METHOD FOR PREPARING AZOXYSTROBIN AND INTERMEDIATE THEREOF DNMT3L, AZI2, DNMT3A ALDH1A1 1704/4885SMN1; SMN2 2720/4885MEN1 303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.